slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
178.700 KRW | +3,35% | +0,06% | -11,32% |
17/04 | Celltrion, Inc. (KOSE:A068270) kondigt een aandeleninkoopprogramma aan voor 436.047 aandelen. | CI |
17/04 | Celltrion, Inc. autoriseert een terugkoopplan. | CI |
Vakgebied
Aantal werknemers: 2 034
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biopharmaceutical
86,1
%
| 1 937 469 | 84,8 % | 1 873 430 | 86,1 % | -3,31% |
Chemical Drugs
23,0
%
| 653 519 | 28,6 % | 500 777 | 23,0 % | -23,37% |
Reconciling Items
-9,3
%
| -310 898 | -13,6 % | -202 919 | -9,3 % | -34,73% |
Others
0,2
%
| 3 877 | 0,2 % | 5 143 | 0,2 % | +32,66% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
97,1
%
| 2 090 465 | 91,5 % | 2 113 156 | 97,1 % | +1,09% |
Asia
2,9
%
| 62 069 | 2,7 % | 63 275 | 2,9 % | +1,94% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 62 | 24-04-07 |
Ho-Seop Lee
DFI | Director of Finance/CFO | 49 | - |
Jung-Jin Seo
CHM | Chairman | 66 | - |
Sung-Han Lee
CMP | Compliance Officer | 42 | - |
Yoon-Mo Koo
PRN | Corporate Officer/Principal | 54 | - |
Sang-Joon Lee
PRN | Corporate Officer/Principal | 57 | - |
Shin-Jae Jang
PRN | Corporate Officer/Principal | 60 | - |
Jung-Won Yoon
PRN | Corporate Officer/Principal | 57 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Soon-Woo Lee
BRD | Director/Board Member | 73 | - |
Jung-Jin Seo
CHM | Chairman | 66 | - |
Jae-Sik Lee
BRD | Director/Board Member | 66 | - |
Dong-Il Kim
BRD | Director/Board Member | 65 | 17-07-08 |
Joseph Lee
BRD | Director/Board Member | 66 | 17-07-08 |
Wu-Sung Ki
CEO | Chief Executive Officer | 62 | 24-04-07 |
Geun-Young Kim
BRD | Director/Board Member | 64 | - |
Dae-Hyeon Yoo
BRD | Director/Board Member | 65 | - |
Hyeok-Jae Lee
BRD | Director/Board Member | 48 | - |
Young-Hye Ko
BRD | Director/Board Member | 69 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 225 966 951 | 143 865 451 ( 63,67 %) | 13 082 991 ( 5,790 %) | 63,67 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
CELLTRION PHARM, INC. 54.81% | 22 797 613 | 54.81% | 1 779 780 238 $ |
CELLTRION, INC. 2.07% | 4 508 124 | 2.07% | 640 262 434 $ |
BIOTOXTECH CO., LTD. 10.22% | 1 631 134 | 10.22% | 7 269 671 $ |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-11,32% | 26,87 mld. | |
-0,02% | 42,11 mld. | |
+43,29% | 40,08 mld. | |
+5,04% | 40 mld. | |
+5,25% | 24,58 mld. | |
-23,83% | 18,44 mld. | |
-1,62% | 11,94 mld. | |
+22,75% | 11,66 mld. | |
+6,44% | 11,01 mld. | |
-18,61% | 9,87 mld. |
- Beurs
- Aandelen
- Koers A068270
- Onderneming Celltrion, Inc.